NCT02329561COMPLETEDanonymous

Comparative, Randomized, Double-Blind, Single-Dose, 2-way Crossover Study to Evaluate the Pharmacokinetics and Analgesic Effect of Labopharm Tramadol Contramid® OAD 200 mg Tablets or Placebo in Healthy Young and Elderly Adult Volunteers

Sponsor

Source record

Université de Montréal

Phase

Source record

PHASE1

Modality

AI-normalized

small molecule

Target

AI-normalized

Tramadol and O-desmethyltramadol enantiomers

Indication / condition

AI-normalized

Aging

Intervention

Source record

Tramadol extended release 200 mg, CP/T, Placebo

Related intelligence directories

Indication directory: Aging Modality directory: small molecule Target directory: Tramadol and O-desmethyltramadol enantiomers

Source & freshness

Source record

NCT ID

NCT02329561

Original source

ClinicalTrials.gov

Source last updated

Dec 31, 2014

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT02329561

Title

Comparative, Randomized, Double-Blind, Single-Dose, 2-way Crossover Study to Evaluate the Pharmacokinetics and Analgesic Effect of Labopharm Tramadol Contramid® OAD 200 mg Tablets or Placebo in Healthy Young and Elderly Adult Volunteers

Sponsor

Université de Montréal

Status

COMPLETED

Phase

PHASE1

Condition raw

Aging

Condition normalized

Aging

Modality raw

Aging

Modality normalized

small molecule

Target raw

Tramadol and O-desmethyltramadol enantiomers

Target normalized

Tramadol and O-desmethyltramadol enantiomers

Interventions

Tramadol extended release 200 mg, CP/T, Placebo

Public preview

Source record

This completed clinical trial evaluated the pharmacokinetics and pharmacodynamics of tramadol and its active metabolite, O-desmethyltramadol, in healthy young and elderly adults. The study aimed to understand age-related differences in drug metabolism and analgesic effects, which could inform dosing and safety profiles for geriatric patients.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

Investment-Ready Snapshot

Comparative, Randomized, Double-Blind, Single-Dose, 2-way Crossover Study to Evaluate the Pharmacokinetics and Analgesic Effect of Labopharm Tramadol Contramid® OAD 200 mg Tablets or Placebo in Healthy Young and Elderly Adult Volunteers

Source & freshness

Public preview

Create an account to unlock this report

Comparative, Randomized, Double-Blind, Single-Dose, 2-way Crossover Study to Evaluate the Pharmacokinetics and Analgesic Effect of Labopharm Tramadol Contramid® OAD 200 mg Tablets or Placebo in Healthy Young and Elderly Adult Volunteers

Investment-Ready Snapshot

Provenance

Protocol Description

Outcome Measures

Eligibility

Known Results And Readout Context

Patent And IP Landscape

Contacts